Zhou Rong's Form 4 filing
Amphastar Pharmaceuticals, Inc. (AMPH) · filed Sep 17, 2024
- Accession no.
- 0001415889-24-023514
- Filed
- Sep 17, 2024
- Trade date
- Sep 13, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $144.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zhou RongCIK 0001645326 | Officer (SENIOR EVP, PRODUCTION CENTER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | Common Srock | MOption exerciseAcquired | +3,000 | $14.95 | +$44,850 | 121,388 | Direct | |
| Sep 13, 2024 | Common Srock | SSaleDisposed | −3,000 | $48.26 | −$144,780 | 118,388 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | Common Stock | MOption exerciseDisposed | −3,000 | $0.00 | $0 | 6,893 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.